nimorazole has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horsman, MR; Wittenborn, TR | 1 |
| Nielsen, OS; Overgaard, J; Overgaard, M; Pedersen, AK; Timothy, AR | 1 |
| Overgaard, J; Zachariae, C | 1 |
3 other study(ies) available for nimorazole and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Targeting tumour hypoxia to improve outcome of stereotactic radiotherapy.
Topics: Administration, Inhalation; Animals; Carbon Dioxide; Cell Hypoxia; Diphosphates; Female; Hyperthermia, Induced; Mammary Neoplasms, Experimental; Mice, Inbred C3H; Niacinamide; Nimorazole; Oxygen; Radiation-Sensitizing Agents; Radiosurgery; Radiotherapy Dosage; Stilbenes; Vitamin B Complex | 2015 |
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Misonidazole; Nimorazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1982 |
Interactions of radiation, cyclophosphamide and nimorazole in a C3H mammary carcinoma in vivo.
Topics: Animals; Combined Modality Therapy; Cyclophosphamide; Mammary Neoplasms, Experimental; Mice; Nimorazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |